Bryan L. Walser
Keine laufenden Positionen mehr
Profil
Bryan L.
Walser was the founder of Aimmune Therapeutics, Inc. (founded in 2011) where he held the title of Director in 2015.
He was also a former Chief Executive Officer at Perlegen Sciences, Inc., a Director at GeneFluidics, Inc., a Member at Chiron Corp., and a Project Leader & Special Adviser at The Boston Consulting Group, Inc. Dr. Walser holds a doctorate from the University of Virginia, a graduate degree from Harvard University, and an undergraduate degree from Stanford University.
Ehemalige bekannte Positionen von Bryan L. Walser
| Unternehmen | Position | Ende |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | Gründer | 01.05.2015 |
GeneFluidics, Inc.
 GeneFluidics, Inc. Medical SpecialtiesHealth Technology GeneFluidics, Inc. develops and distributes technology to find and identify DNA and RNA, proteins and small molecules without the use of amplification methods. The company serves the markets which include clinical diagnostics, animal testing, environmental monitoring and biothreat detection. The company was founded by Vincent J. Gau in 2000 and is headquartered in Monterey Park, CA. | Direktor/Vorstandsmitglied | - |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | - |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Perlegen Sciences, Inc.
 Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA | Vorstandsvorsitzender | - |
Ausbildung von Bryan L. Walser
| Stanford University | Undergraduate Degree |
| University of Virginia | Doctorate Degree |
| Harvard University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Perlegen Sciences, Inc.
Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA | Retail Trade |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Commercial Services |
GeneFluidics, Inc.
GeneFluidics, Inc. Medical SpecialtiesHealth Technology GeneFluidics, Inc. develops and distributes technology to find and identify DNA and RNA, proteins and small molecules without the use of amplification methods. The company serves the markets which include clinical diagnostics, animal testing, environmental monitoring and biothreat detection. The company was founded by Vincent J. Gau in 2000 and is headquartered in Monterey Park, CA. | Health Technology |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |